The Parliamentary Standing Committee on Health and Family Welfare tabled its 176th Report in Parliament on August 7, 2026. It found that the average cost of hospitalisation is ₹50,508 in a private facility, against ₹6,631 in a government facility. For childbirth, average out-of-pocket spending is ₹37,630 in private facilities, against ₹2,299 in public ones. The country needs private capital to expand health care, the author argues, but that investment cannot be allowed to shape clinical decisions, pricing and access.

What Did the Committee Recommend?

368 recommendations: these include standardised package rates and mandatory pre-treatment cost estimates.
Room tariffs: basic room tariffs in metropolitan private hospitals should not exceed the average tariff of nearby three-star hotels.
Cross-subsidy: large corporate hospitals earning from medical tourism, foreign patients and high-net-worth individuals should cross-subsidise poorer patients. They should also reserve beds for Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) beneficiaries at regulated rates.
The contradiction: India wants more private and foreign capital in health care, especially in Tier-2, Tier-3 and rural areas. Yet it is simultaneously asking the government to review FDI rules on the acquisition of existing hospitals.

Why Does Private Capital Need Careful Regulation in Health Care?

Information asymmetry: unlike ordinary consumers, patients rarely decide independently whether an MRI is required, admission should continue, or a procedure is necessary.
When financial incentives grow too strong, the author argues, they can shape not just the price of care but how much care is delivered.
Rising costs from competition: corporate hospitals compete for specialists, technology and premium infrastructure, which improves quality but also creates a high-cost ecosystem.
Medicalisation risk: revenue targets and procedure-linked incentives can gradually influence institutional behaviour. This can lead to unnecessary tests, admissions and procedures, such as caesarean sections and angioplasties.

What Should an FDI Review Actually Ask?

Not who invests, but what changes: does an investment create new beds, or simply acquire existing ones?
Does it improve competition, or lead to market concentration?
Does it enter an underserved district, or add another high-end facility in a metro?
Where an investor receives concessional land or tax benefits, are there enforceable obligations on affordable beds or public-insurance participation?

Why Are Simple Price Caps Not Enough?

Capping room tariffs to nearby three-star hotel rates is easy to understand. But a hospital room includes nursing, infection control and emergency support that a hotel room does not.
If one component of the bill is capped, hospitals may simply raise charges elsewhere.
India's coronary stent price regulation showed that government intervention can reduce excessive mark-ups. But hospital care is more complex, and what matters most is the total cost of an episode.
A better approach: package rates, transparent cost estimates, billing standards and audit mechanisms.
One established model is Diagnosis-Related Groups (DRG): a fixed, pre-determined payment per inpatient stay based on diagnosis and procedures, not per service.

What Is the Larger Policy Fix?

India cannot regulate its way out of weak public health care. OECD experience shows a strong public health system is the most effective check on private prices.
Public hospitals must become a genuine option, not merely the last resort for those who cannot afford private care.
Insurance schemes, including AB-PMJAY, should reward appropriate care rather than a higher volume of procedures.

Conclusion

The Committee is right to question whether India's pattern of private investment in health care serves the public interest. Price caps and an FDI review are reasonable starting points, but a wider conversation is needed on the kind of health-care system India is building. Private investment remains essential, and profit is not itself the problem. The problem begins when the pursuit of returns starts shaping clinical decisions, pricing and access.

Mains Angle

GS Paper II (Health, Governance): this piece is useful for questions on health-care financing, FDI regulation, and the design of provider-payment systems. Practice question: "Private capital is essential to expand India's health-care capacity, but it introduces incentives that can distort clinical decision-making. Discuss, with reference to the recommendations of the 176th Report of the Parliamentary Standing Committee on Health and Family Welfare." (15 marks, 250 words)